Voyager Therapeutics share price logo

Voyager Therapeutics

NASDAQ: VYGR

$1.90

-0.16

(-7.77%)

as on

Voyager Therapeutics Stock Performance

as on October 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.89
    $2.05
    downward going graph

    0.53%

    Downside

    7.89%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.89
    $5.48
    downward going graph

    0.53%

    Downside

    188.32%

    Upside

    downward going graph

Voyager Therapeutics share price movements today

Previous Close
$2.06
Open
$2.04
Volume
620.2K
Market Cap
$126.9M
Day's Low - High
$1.89 - $2.05
52 Week Low - High
$1.89 - $5.48

Voyager Therapeutics Historical Returns

1 Month Return
-37.5 %
3 Month Return
-40.06 %
1 Year Return
-61.62 %
3 Year Return
-74.87 %
5 Year Return
-53.66 %

Voyager Therapeutics Stock Fundamentals & Key Indicators

Check Voyager Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$126.9M

EPS (TTM)

-1.81

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.14

Industry PE ratio

-3.02

PEG Ratio

0.64

EBITDA

-103.8M

Revenue (TTM)

34.5M

Profit Margin

100.00%

Return On Equity TTM

-57.92%

Voyager Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Voyager Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Voyager Therapeutics image
Voyager Therapeutics
StrongBuy$126.9M-53.66%-1.14100.00%0.00%
Moderna image
Moderna
Neutral$94.4B-32.76%-29.64-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$128.9B174.93%29.3786.04%0.00%
Regeneron image
Regeneron
Buy$80.1B42.93%19.0184.86%0.46%

Stock Returns calculator for Voyager Therapeutics Stock including INR - Dollar returns

The Voyager Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Voyager Therapeutics investment value today

Current value as on today

₹41,418

Returns

-₹58,582

(-58.58%)

Returns from Voyager Therapeutics Stock

-₹61,616 (-61.62%)

Dollar Impact

₹3,035 (+3.03%)

Analyst Recommendation on Voyager Therapeutics Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Voyager Therapeutics. Average target price of $14.89

Voyager Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Voyager Therapeutics.

What analysts predicted

87.24%UPSIDE

Target Price

$14.89

Current Price

$1.9

Analyzed by

3 Analysts

High

$25

Target

$14.89

Low

$12

Voyager Therapeutics target price $14.89, a slight upside of 87.24% compared to current price of $1.9. According to 3 analysts rating.

Indian Investors' Interest in Voyager Therapeutics Stock

Search interest for Voyager Therapeutics Stock has increased by 468% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:468% versus previous 30 day period

Voyager Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
19
29
24
6
6
5
13
15
2
3
Gross Profit
18
29
24
6
6
5
13
15
2
3
Operating Income
-16
-15
-13
-38
-34
-36
-30
-29
-30
-26
EBITDA
-10
-8
-7
-32
-29
-32
-26
-26
-26
-23
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
0
1
0
0
Income Before Tax
-11
-10
-9
-33
-30
-33
-27
-27
-27
-24
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-11
-10
-9
-34
-31
-33
-27
-27
-27
-24
Net Profit Margin
93.87%
-8.03%
100.00%
-422.57%
-387.04%
100.00%
100.00%
100.00%
100.00%
100.00%

Voyager Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
10
7
104
171
37
40
250
80
40
Gross Profit
-52
-57
-15
62
-36
-14
157
80
-91
Operating Income
-71
-91
-51
27
-73
-50
122
-83
-131
EBITDA
-70
-88
-48
31
-66
-39
138
-59
-115
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
1
2
2
3
5
6
4
4
4
Income Before Tax
-70
-88
-43
36
-71
-46
133
-64
-119
Income Tax Expense
-
0
-
-
-
0
1
0
0
Net Income
-70
-88
-43
36
-71
-46
132
-65
-119
Net Profit Margin
-514.31%
-751.88%
-14.70%
36.45%
-97.21%
-36.32%
63.13%
100.00%
-227.62%

Voyager Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
-10
-9
-34
-31
-33
-27
-27
-27
-24
Operating Cash Flow
58
-31
-27
-14
-37
-33
-31
-30
-33
-25
Investing Cash Flow
-96
-35
64
-27
41
1
34
47
8
15
Financing Cash Flow
112
0
0
0
0
0
0
0
3
2
Change in Cash
75
-66
36
-41
3
-30
1
17
-21
-7

Voyager Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-70
-88
-43
36
-71
-46
132
-65
-119
Operating Cash Flow
-61
-15
48
-96
-53
-12
77
-15
-132
Investing Cash Flow
-3
26
-90
112
65
-7
-141
-94
125
Financing Cash Flow
59
4
80
3
0
1
33
114
0
Change in Cash
-5
15
39
18
12
-18
-30
3
-6

Global Institutional Holdings in Voyager Therapeutics

Check out the Institutions with significant holdings in Voyager Therapeutics.

Funds
Holdings
Vanguard
4.29%
iShares
4.12%
VANGUARD INDEX FUNDS
3.60%
BlackRock Funds
1.08%
Fidelity Salem Street Trust
0.85%
See all

Insights on Voyager Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.59M → 3.16M (in $), with an average increase of 18.1% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -27.93M → -24.47M (in $), with an average increase of 14.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 152.5% return, outperforming this stock by 227.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 799.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, VYGR stock has moved down by -22.4%

About Voyager Therapeutics

Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. Additionally, Voyager is pursuing a Tau program aimed at various tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, alongside initiatives for spinal muscular atrophy. To advance its gene therapy product pipeline, the company has forged strategic collaboration and licensing agreements with key industry players such as Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. These partnerships cover the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and maintains its corporate headquarters in Cambridge, Massachusetts.
OrganisationVoyager Therapeutics
Headquarters75 Sidney Street, Lexington, MA, 02421, US
IndustryBiotechnology
CEOAlfred W. Sandrock Jr.

Key Management of Voyager Therapeutics

Name

Title

Ms. Robin Swartz

Principal Financial Officer, Treasurer, Chief Business Officer & COO

Dr. Mark A. Kay M.D., Ph.D.

Founder

Mr. Todd Carter Ph.D.

Chief Scientific Officer

Ms. Trista Morrison

Chief Corporate Affairs Officer & Chief of Staff to the CEO

Dr. Mathieu Nonnenmacher Ph.D.

Vice President of Gene Therapy

Dr. Alfred W. Sandrock Jr., M.D., Ph.D.

President, CEO & Director

Dr. Krystof Bankiewicz M.D., Ph.D.

Founder

Ms. Amy Quinlan

Principal Accounting Officer

Mihalis Kariolis

Vice President of Non-Viral Therapeutics

FAQs

What is Voyager Therapeutics share price today?

Voyager Therapeutics share price today is $1.90 as on at the close of the market. Voyager Therapeutics share today touched a day high of $2.05 and a low of $1.89.

What is the 52 week high and 52 week low for Voyager Therapeutics share?

Voyager Therapeutics share touched a 52 week high of $5.48 on and a 52 week low of $1.89 on . Voyager Therapeutics stock price today i.e. is closed at $1.90,which is 65.32% down from its 52 week high and 0.53% up from its 52 week low.

What is Voyager Therapeutics's market capitalisation today?

Voyager Therapeutics market capitalisation is $0.00T as on .

How to invest in Voyager Therapeutics Stock (VYGR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Voyager Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Voyager Therapeutics Stock (VYGR) from India?

Indian investors can start investing in Voyager Therapeutics (VYGR) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Voyager Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Voyager Therapeutics share’s latest price of $1.90 as on October 17, 2026 at 8:45 am IST, you will get 5.2632 shares of Voyager Therapeutics. Learn more about fractional shares .

What are the returns that Voyager Therapeutics has given to Indian investors in the last 5 years?

Voyager Therapeutics stock has given -53.66% share price returns and 26.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?